between breast cancer risk factors and false-positive recalls may help reduce their occurrence. Previous studies have found that high breast density is associated with false-positive recalls. 11 – 13 However, no study thus far has investigated the
Search Results
Factors Associated With False-Positive Recalls in Mammography Screening
Xinhe Mao, Wei He, Keith Humphreys, Mikael Eriksson, Natalie Holowko, Fredrik Strand, Per Hall, and Kamila Czene
Risk Assessment and Prophylaxis for VTE in Cancer Patients
Alok A. Khorana
.medscape.org/journal/jnccn ; (4) view/print certificate. Release date: July 5, 2011; Expiration date: July 5, 2012 Learning Objectives Upon completion of this activity, participants will be able to: Describe clinical risk factors for VTE in cancer, based on a review Describe
Contemporary Radiation Therapy in Combined Modality Therapy for Hodgkin Lymphoma
Amol K. Narang and Stephanie A. Terezakis
considered a standard regimen, with a higher number of chemotherapy cycles and/or radiation dose depending on number of risk factors, initial bulk, and response to treatment. Table 1 Definitions of Unfavorable Risk Factors by Specific Cooperative
Determining Chemotherapy Tolerance in Older Patients With Cancer
Jerome Kim and Arti Hurria
such as diabetes mellitus are associated with an increased risk of mortality in older adults with cancer, 27 , 28 whereas organ dysfunction such as renal insufficiency is a risk factor for chemotherapy toxicity. 7 , 8 Medications: Close to one
Late Cardiovascular Toxicity Following Chemotherapy for Germ Cell Tumors
Darren R. Feldman, Wendy L. Schaffer, and Richard M. Steingart
. 15 – 18 For example, higher rates of digital ischemia were identified in patients treated with cisplatin compared with those who were not (41% vs. 21%). 14 The cumulative dose of chemotherapy and the prevalence of conventional risk factors for
Risk Factors for the Assessment of Patients with Pulmonary Embolism
John Fanikos and Samuel Z. Goldhaber
: a 25 year population based study . Arch Intern Med 1998 ; 15 : 585 – 593 . 5. Heit JA Silverstein MD Mohr DN . Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study . Arch Intern Med
Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma
James J. Harding, Ghaith Abu-Zeinah, Joanne F. Chou, Dwight Hall Owen, Michele Ly, Maeve Aine Lowery, Marinela Capanu, Richard Do, Nancy E. Kemeny, Eileen M. O'Reilly, Leonard B. Saltz, and Ghassan K. Abou-Alfa
's test was used to compare the cumulative incidence functions by covariates of interest including age, sex, race, treatment era, HCC etiologic risk factor, Child-Pugh score, AFP level, and median calcium and ALP levels. Among patients who presented with
An Update on the Role of Interim Restaging FDG-PET in Patients With Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma
Craig H. Moskowitz, Andrew Zelenetz, and Heiko Schoder
stages II, III, or IV disease and 1 to 3 risk factors according to age-adjusted International Prognostic Index score. After induction therapy with 4 cycles of R-CHOP-14, all patients underwent FDG-PET. Patients who had negative FDG-PET results then
NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening
Brady J. McKee, Shawn Regis, Andrea K. Borondy-Kitts, Jeffrey A. Hashim, Robert J. French Jr, Christoph Wald, and Andrea B. McKee
(NLST) entry criteria. 1 – 4 All 3 organizations have expanded their screening recommendations to include older patients, younger patients, and/or patients with additional risk factors for lung cancer. Inclusion of these additional populations has
CLO23-052: Risk Factors and Prognosis of Stroke in Gynecologic Cancer
Ji Young Kwon, Jeong Min Song, Young Shin Chung, Kwang-Beom Lee, and Jong-Min Lee
This is a retrospective cohort study of cervical, ovarian, and endometrial cancer patients to investigate the risk factors and prognosis of stroke. Patients who experienced stroke around the time of cancer diagnosis and treatment were categorized
